Skip to main content

Table 5 Procedure-related complications and 30-day outcomes

From: Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgery

  Isolated MVS (N = 182) MVS + TVR (N = 182) P-value
Procedure-related complications
 Postoperative mortality, % 1.6 1.1 1.000
 Wound infection, % 3.3 3.3 1.000
 Pericardial tamponade, % 6.6 8.2 0.548
 AV block grade III, % 9.3 14.3 0.144
 Pneumonia, % 8.2 11.0 0.374
 Pneumothorax, % 0.5 0.5 1.000
 Pleural effusion, % 3.3 6.0 0.214
 Atrial Fibrillation, % 29.3 34.6 0.276
30-day complications
 Death, % 7.7 5.5 0.398
  CV death, % 4.9 3.3 0.429
  Non-CV death, % 2.7 2.2 1.000
 Stroke, % 7.1 3.8 0.168
 Acute renal failure, % 12.2 12.6 0.889
 Myocardial infarction, % 0 0 n.a.
 Pacemaker implantation, % 8.8 16.0 0.037
 Repeat MV surgery, % 1.1 0.5 1.000
  1. Legend: values are percentage or median [interquartile range]
  2. AV atrioventricular, CV cardiovascular, MV mitral valve, MVS mitral valve surgery, TVR tricuspid valve repair